Finasteride
This Medication is for Use in Men Only
Package Leaflet Contents:
Finasteride, the Active Substance of Finxta, is a 5-Alpha Reductase Inhibitor, an Enzyme that Converts Testosterone (Male Sex Hormone) into a More Potent Dihydrotestosterone (DHT). Finxta Causes a Reduction in the Size of the Prostate Gland.
Finxta is Used to Treat a Condition Called Benign Prostatic Hyperplasia (BPH). The Prostate Gland, Located in the Area of the Urinary Bladder, Enlarges in this Condition, Causing Difficulty in Urinating.
Finxta is Indicated for the Treatment of Benign Prostatic Hyperplasia to:
If Your Sexual Partner is Pregnant or May be Pregnant, You Should Avoid Exposing her to Your Semen, which may Contain Small Amounts of the Medication.
Finxta is Not Indicated for Use in Women.
Before Starting Treatment with Finxta, You Should Discuss it with Your Doctor.
You Should Inform Your Doctor about any Current or Past Medical Conditions and Allergies.
Benign Prostatic Hyperplasia is a Condition that Develops Over Many Years, and Symptoms may not be Noticeable Until Later. Finxta may Relieve Symptoms and Allow for Control of the Disease if Taken Regularly for a Long Time.
Patients Taking Finxta have Reported Mood Changes, such as Depressive Mood, and Depression, and Rarely, Suicidal Thoughts. If You Experience any of these Symptoms, You Should Immediately Consult Your Doctor for Further Medical Advice.
Finxta is Not Indicated for Use in Children.
You Should Tell Your Doctor or Pharmacist about all Medications You are Currently Taking or Plan to Take.
Finxta Usually Does Not Affect the Action of Other Medications.
Pregnancy
Women who are Pregnant or May Become Pregnant Should Not Take Finxta. They Should Also Not Handle Crushed or Broken Finxta Tablets. If the Active Substance of Finxta Enters the Body (Orally or Through Skin Contact), it may Cause Abnormalities of the Male Genitalia in the Fetus. If a Pregnant Woman is Exposed to the Active Substance of Finxta, She Should Inform Her Doctor. The Film-Coated Tablets of Finxta Prevent Direct Contact with the Active Substance, Provided that the Tablets are Not Damaged or Crushed.
More Information is Available from Your Doctor.
Breastfeeding
Finxta is Not Indicated for Use in Women.
It is Not Known if Finasteride Passes into Human Milk.
There are No Data to Suggest that Finxta Affects the Ability to Drive or Use Machines.
The Medication Contains Lactose. If You have been Diagnosed with an Intolerance to Some Sugars, You Should Consult Your Doctor Before Taking the Medication.
This Medication Should Always be Taken Exactly as Prescribed by Your Doctor. If You are Unsure, Consult Your Doctor or Pharmacist.
The Recommended Dose is One 5 mg Tablet per Day, Regardless of Meals.
The Medication Should be Taken Orally. The Film-Coated Tablets Should be Swallowed Whole. Do Not Divide or Crush Them.
You Should Remember that Benign Prostatic Hyperplasia is a Long-Term Condition, and Symptoms may not be Noticeable Until Later. Finxta may Relieve Symptoms and Allow for Control of the Disease if Taken Regularly for a Long Time.
No Dose Adjustment is Required in Patients with Renal Impairment of any Degree or Hepatic Impairment.
No Dose Adjustment is Required in the Elderly.
If You Feel that the Effect of Finxta is Too Strong or Too Weak, Consult Your Doctor or Pharmacist.
If You Take More than the Recommended Dose, Consult Your Doctor Immediately.
Take Finxta as Prescribed by Your Doctor. However, if You Miss a Dose, Do Not Take a Double Dose to Make Up for the Missed Dose. The Next Day, Continue with the Prescribed Dose. If You Have Any Further Questions on the Use of this Medication, Ask Your Doctor or Pharmacist.
Like all Medications, Finxta can Cause Side Effects, although not Everybody gets them.
Common(may affect up to 1 in 10 people)
In Some Cases, these Symptoms may Disappear During Treatment. However, if the Side Effects Persist, You Should Consult Your Doctor, who may Decide to Stop Treatment with Finxta.
Uncommon(may affect up to 1 in 100 people)
Unknown(frequency cannot be estimated from the available data)
You Should Stop Taking Finxta and Immediately Consult Your Doctor if You Experience any of the Following Symptoms (Angioedema): Face, Lip, Tongue, or Throat Swelling, Difficulty Swallowing, Hives, and Difficulty Breathing.
If You Experience any Side Effects, including those not Listed in this Package Leaflet, Tell Your Doctor or Pharmacist. You can Report Side Effects Directly to the Department of Medicinal Product Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl.
You can also Report Side Effects to the Marketing Authorization Holder.
By Reporting Side Effects, You can Help Provide More Information on the Safety of this Medication.
Keep this Medication out of the Sight and Reach of Children.
There are No Special Precautions for Storage.
Do Not Use this Medication after the Expiry Date Stated on the Carton after “Expiry Date” and on the Blister after “EXP”. The Expiry Date Refers to the Last Day of the Month Stated.
Medications Should Not be Disposed of via Wastewater or Household Waste. Ask Your Pharmacist how to Dispose of Medications that are No Longer Needed. This will Help Protect the Environment.
Finxta is a White, Round, Biconvex Film-Coated Tablet with a Diameter of 7 mm, with “F” and “5” Engraved on One Side.
PVC/PVDC/Aluminum Blisters Containing: 15, 28, 30, 50, 98, and 100 Film-Coated Tablets.
Not all Pack Sizes may be Marketed.
Recordati Polska sp. z o.o.
al. Armii Ludowej 26
00-609 Warsaw
Tel. 22 206 84 50
Haupt Pharma Münster GmbH
Schleebrüggenkamp 15
48159 Münster
Germany
Siegfried Malta Ltd
HHF070 Hal Far Industrial Estate
Hal Far BBG3000
Malta
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.